Early research (Phase 1)Study completedNCT05466422
What this trial is testing
MK-2214 in Adults With Mild Cognitive Impairment or Mild-to-Moderate Alzheimer's Disease (MK-2214-002)
Who this might be right for
Alzheimer Disease
Merck Sharp & Dohme LLC 34